Features

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who take risks in uncertain times”

Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease Nurse...

Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss looks into the...

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund...

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores the roots of...

“It really is about having a dream and figuring out how to go about accomplishing that dream”

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders...

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI and big data are...

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout her teens, Niamh ni Ruari...

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done to improve the way...